Not for nothing, posting about other companies has no bearing on this company, and does not belong on this board. If you have news from management please post, if you have articles referring to our drug, please post. The facts are, management owes us an update.
I wonder if lenzilumab's enhancement of the Novavax prototype vaccine led to the settlement of the litigation against Novavax in this regard, which read as follows:
Novavax, "...made certain purportedly false and misleading statements concerning the Company’s ability to manufacture prototype vaccine on a commercial scale and to secure the prototype vaccine’s regulatory approval."
News 
Market Data 
Discover 
